KKR Puts Up $1.3B For Clinical Trial Provider PRA
New York private equity titan KKR & Co. LP on Monday unveiled plans to lift ownership of clinical laboratory testing provider PRA International from fellow investment firm Genstar Capital LLC in...To view the full article, register now.
Already a subscriber? Click here to view full article